APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plasmid DNA CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Plasmid DNA CDMO Service Market Outlook and Growth Opportunities 2026

Report ID 17421664045 June 2026208 pages

Choose your research edition.

Industry ResearchPlasmid DNA CDMO Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasmid DNA CDMO Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Plasmid DNA CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasmid DNA CDMO Service Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasmid DNA CDMO Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Plasmid DNA CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Plasmid DNA CDMO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Plasmid DNA CDMO Service market include Creative Biogene, AGC Biologics, Biovian, GenScript ProBio, Charles River Laboratories, PackGene, Catalent Biologics, Patheon and Mycenax Biotech Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Plasmid DNA CDMO Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Plasmid DNA CDMO Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Plasmid DNA CDMO Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Plasmid DNA CDMO Service market.

Plasmid DNA CDMO Service Segment by Company

Creative Biogene

AGC Biologics

Biovian

GenScript ProBio

Charles River Laboratories

PackGene

Catalent Biologics

Patheon

Mycenax Biotech Inc

VGXI

Esco Aster

Eurogentec

53Biologics

SK pharmteco

Cytovance Biologics

Aldevron

Bionova Scientific

Plasmid DNA CDMO Service Segment by Type

Research Grade

Commercial Grade

GMP Grade

Others

Plasmid DNA CDMO Service Segment by Application

Preclinical

Clinical

Commercial

Plasmid DNA CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Plasmid DNA CDMO Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Plasmid DNA CDMO Service key companies, revenue, market share, and recent developments.

3. To split the Plasmid DNA CDMO Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Plasmid DNA CDMO Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Plasmid DNA CDMO Service significant trends, drivers, influence factors in global and regions.

6. To analyze Plasmid DNA CDMO Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasmid DNA CDMO Service industry.

Chapter 3: Detailed analysis of Plasmid DNA CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Plasmid DNA CDMO Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Plasmid DNA CDMO Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Plasmid DNA CDMO Service Industry Trends Table 2. Plasmid DNA CDMO Service Industry Drivers Table 3. Plasmid DNA CDMO Service Industry Opportunities and Challenges Table 4. Plasmid DNA CDMO Service Industry Restraints Table 5. Global Plasmid DNA CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Plasmid DNA CDMO Service Revenue Share by Company (2021-2026) Table 7. Global Plasmid DNA CDMO Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Plasmid DNA CDMO Service Key Company Manufacturing Base & Headquarters Table 9. Global Plasmid DNA CDMO Service Company, Product Type & Application Table 10. Global Plasmid DNA CDMO Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Plasmid DNA CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Research Grade Table 15. Significant Companies of Commercial Grade Table 16. Significant Companies of GMP Grade Table 17. Significant Companies of Others Table 18. Global Plasmid DNA CDMO Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Plasmid DNA CDMO Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Plasmid DNA CDMO Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Plasmid DNA CDMO Service Sales Value Share by Type (2021-2026) Table 22. Global Plasmid DNA CDMO Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Preclinical Table 24. Significant Companies of Clinical Table 25. Significant Companies of Commercial Table 26. Global Plasmid DNA CDMO Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Plasmid DNA CDMO Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Plasmid DNA CDMO Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Plasmid DNA CDMO Service Sales Value Share by Application (2021-2026) Table 30. Global Plasmid DNA CDMO Service Sales Value Share by Application (2027-2032) Table 31. Global Plasmid DNA CDMO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Plasmid DNA CDMO Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Plasmid DNA CDMO Service Sales Value Share by Region (2021-2026) Table 34. Global Plasmid DNA CDMO Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Plasmid DNA CDMO Service Sales Value Share by Region (2027-2032) Table 36. Global Plasmid DNA CDMO Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Plasmid DNA CDMO Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Plasmid DNA CDMO Service Sales Value Market Share by Country (2021-2026) Table 39. Global Plasmid DNA CDMO Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Plasmid DNA CDMO Service Sales Value Market Share by Country (2027-2032) Table 41. Creative Biogene Company Information Table 42. Creative Biogene Business Overview Table 43. Creative Biogene Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Creative Biogene Plasmid DNA CDMO Service Product Portfolio Table 45. Creative Biogene Recent Development Table 46. AGC Biologics Company Information Table 47. AGC Biologics Business Overview Table 48. AGC Biologics Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. AGC Biologics Plasmid DNA CDMO Service Product Portfolio Table 50. AGC Biologics Recent Development Table 51. Biovian Company Information Table 52. Biovian Business Overview Table 53. Biovian Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Biovian Plasmid DNA CDMO Service Product Portfolio Table 55. Biovian Recent Development Table 56. GenScript ProBio Company Information Table 57. GenScript ProBio Business Overview Table 58. GenScript ProBio Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. GenScript ProBio Plasmid DNA CDMO Service Product Portfolio Table 60. GenScript ProBio Recent Development Table 61. Charles River Laboratories Company Information Table 62. Charles River Laboratories Business Overview Table 63. Charles River Laboratories Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Charles River Laboratories Plasmid DNA CDMO Service Product Portfolio Table 65. Charles River Laboratories Recent Development Table 66. PackGene Company Information Table 67. PackGene Business Overview Table 68. PackGene Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PackGene Plasmid DNA CDMO Service Product Portfolio Table 70. PackGene Recent Development Table 71. Catalent Biologics Company Information Table 72. Catalent Biologics Business Overview Table 73. Catalent Biologics Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Catalent Biologics Plasmid DNA CDMO Service Product Portfolio Table 75. Catalent Biologics Recent Development Table 76. Patheon Company Information Table 77. Patheon Business Overview Table 78. Patheon Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Patheon Plasmid DNA CDMO Service Product Portfolio Table 80. Patheon Recent Development Table 81. Mycenax Biotech Inc Company Information Table 82. Mycenax Biotech Inc Business Overview Table 83. Mycenax Biotech Inc Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Mycenax Biotech Inc Plasmid DNA CDMO Service Product Portfolio Table 85. Mycenax Biotech Inc Recent Development Table 86. VGXI Company Information Table 87. VGXI Business Overview Table 88. VGXI Plasmid DNA CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. VGXI Plasmid DNA CDMO Service Product Portfolio Table 90. VGXI Recent Development Table 91. Esco Aster Company Information Table 92. Esco Aster Business Overview Table 93. Esco Aster Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Esco Aster Plasmid DNA CDMO Service Product Portfolio Table 95. Esco Aster Recent Development Table 96. Eurogentec Company Information Table 97. Eurogentec Business Overview Table 98. Eurogentec Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Eurogentec Plasmid DNA CDMO Service Product Portfolio Table 100. Eurogentec Recent Development Table 101. 53Biologics Company Information Table 102. 53Biologics Business Overview Table 103. 53Biologics Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. 53Biologics Plasmid DNA CDMO Service Product Portfolio Table 105. 53Biologics Recent Development Table 106. SK pharmteco Company Information Table 107. SK pharmteco Business Overview Table 108. SK pharmteco Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. SK pharmteco Plasmid DNA CDMO Service Product Portfolio Table 110. SK pharmteco Recent Development Table 111. Cytovance Biologics Company Information Table 112. Cytovance Biologics Business Overview Table 113. Cytovance Biologics Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Cytovance Biologics Plasmid DNA CDMO Service Product Portfolio Table 115. Cytovance Biologics Recent Development Table 116. Aldevron Company Information Table 117. Aldevron Business Overview Table 118. Aldevron Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Aldevron Plasmid DNA CDMO Service Product Portfolio Table 120. Aldevron Recent Development Table 121. Bionova Scientific Company Information Table 122. Bionova Scientific Business Overview Table 123. Bionova Scientific Plasmid DNA CDMO Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Bionova Scientific Plasmid DNA CDMO Service Product Portfolio Table 125. Bionova Scientific Recent Development Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Plasmid DNA CDMO Service Product Image Figure 2. Global Plasmid DNA CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasmid DNA CDMO Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasmid DNA CDMO Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Research Grade Image Figure 8. Commercial Grade Image Figure 9. GMP Grade Image Figure 10. Others Image Figure 11. Global Plasmid DNA CDMO Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Plasmid DNA CDMO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Plasmid DNA CDMO Service Sales Value Share by Type (2021-2032) Figure 14. Preclinical Image Figure 15. Clinical Image Figure 16. Commercial Image Figure 17. Global Plasmid DNA CDMO Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Plasmid DNA CDMO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Plasmid DNA CDMO Service Sales Value Share by Application (2021-2032) Figure 20. Global Plasmid DNA CDMO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Plasmid DNA CDMO Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Plasmid DNA CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Plasmid DNA CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Plasmid DNA CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Plasmid DNA CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Plasmid DNA CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Plasmid DNA CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Plasmid DNA CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Plasmid DNA CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Plasmid DNA CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Plasmid DNA CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Research Grade
  • Commercial Grade
  • GMP Grade
  • Others
Applications
  • Preclinical
  • Clinical
  • Commercial
Companies covered
  • Creative Biogene
  • AGC Biologics
  • Biovian
  • GenScript ProBio
  • Charles River Laboratories
  • PackGene
  • Catalent Biologics
  • Patheon
  • Mycenax Biotech Inc
  • VGXI
  • Esco Aster
  • Eurogentec
  • 53Biologics
  • SK pharmteco
  • Cytovance Biologics
  • Aldevron
  • Bionova Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Plasmid DNA CDMO Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Plasmid DNA CDMO Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Plasmid DNA CDMO Service Market Dynamics
  1. 2.1 Plasmid DNA CDMO Service Industry Trends
  2. 2.2 Plasmid DNA CDMO Service Industry Drivers
  3. 2.3 Plasmid DNA CDMO Service Industry Opportunities and Challenges
  4. 2.4 Plasmid DNA CDMO Service Industry Restraints
3 Plasmid DNA CDMO Service Market by Company
  1. 3.1 Global Plasmid DNA CDMO Service Company Revenue Ranking in 2025
  2. 3.2 Global Plasmid DNA CDMO Service Revenue by Company (2021-2026)
  3. 3.3 Global Plasmid DNA CDMO Service Company Ranking (2024-2026)
  4. 3.4 Global Plasmid DNA CDMO Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Plasmid DNA CDMO Service Company Product Type and Application
  6. 3.6 Global Plasmid DNA CDMO Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Plasmid DNA CDMO Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Plasmid DNA CDMO Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Plasmid DNA CDMO Service Market by Type
  1. 4.1 Plasmid DNA CDMO Service Type Introduction
  2. 4.1.1 Research Grade
  3. 4.1.2 Commercial Grade
  4. 4.1.3 GMP Grade
  5. 4.1.4 Others
  6. 4.2 Global Plasmid DNA CDMO Service Sales Value by Type
  7. 4.2.1 Global Plasmid DNA CDMO Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Plasmid DNA CDMO Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Plasmid DNA CDMO Service Sales Value Share by Type (2021-2032)
5 Plasmid DNA CDMO Service Market by Application
  1. 5.1 Plasmid DNA CDMO Service Application Introduction
  2. 5.1.1 Preclinical
  3. 5.1.2 Clinical
  4. 5.1.3 Commercial
  5. 5.2 Global Plasmid DNA CDMO Service Sales Value by Application
  6. 5.2.1 Global Plasmid DNA CDMO Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Plasmid DNA CDMO Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Plasmid DNA CDMO Service Sales Value Share by Application (2021-2032)
6 Plasmid DNA CDMO Service Regional Value Analysis
  1. 6.1 Global Plasmid DNA CDMO Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Plasmid DNA CDMO Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Plasmid DNA CDMO Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Plasmid DNA CDMO Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Plasmid DNA CDMO Service Sales Value (2021-2032)
  7. 6.3.2 North America Plasmid DNA CDMO Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Plasmid DNA CDMO Service Sales Value (2021-2032)
  10. 6.4.2 Europe Plasmid DNA CDMO Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Plasmid DNA CDMO Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Plasmid DNA CDMO Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Plasmid DNA CDMO Service Sales Value (2021-2032)
  16. 6.6.2 South America Plasmid DNA CDMO Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Plasmid DNA CDMO Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Plasmid DNA CDMO Service Sales Value Share by Country, 2025 VS 2032
7 Plasmid DNA CDMO Service Country-level Value Analysis
  1. 7.1 Global Plasmid DNA CDMO Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Plasmid DNA CDMO Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Plasmid DNA CDMO Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Plasmid DNA CDMO Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Plasmid DNA CDMO Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Plasmid DNA CDMO Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Plasmid DNA CDMO Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Creative Biogene
  2. 8.1.1 Creative Biogene Company Information
  3. 8.1.2 Creative Biogene Business Overview
  4. 8.1.3 Creative Biogene Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Creative Biogene Plasmid DNA CDMO Service Product Portfolio
  6. 8.1.5 Creative Biogene Recent Developments
  7. 8.2 AGC Biologics
  8. 8.2.1 AGC Biologics Company Information
  9. 8.2.2 AGC Biologics Business Overview
  10. 8.2.3 AGC Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AGC Biologics Plasmid DNA CDMO Service Product Portfolio
  12. 8.2.5 AGC Biologics Recent Developments
  13. 8.3 Biovian
  14. 8.3.1 Biovian Company Information
  15. 8.3.2 Biovian Business Overview
  16. 8.3.3 Biovian Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biovian Plasmid DNA CDMO Service Product Portfolio
  18. 8.3.5 Biovian Recent Developments
  19. 8.4 GenScript ProBio
  20. 8.4.1 GenScript ProBio Company Information
  21. 8.4.2 GenScript ProBio Business Overview
  22. 8.4.3 GenScript ProBio Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GenScript ProBio Plasmid DNA CDMO Service Product Portfolio
  24. 8.4.5 GenScript ProBio Recent Developments
  25. 8.5 Charles River Laboratories
  26. 8.5.1 Charles River Laboratories Company Information
  27. 8.5.2 Charles River Laboratories Business Overview
  28. 8.5.3 Charles River Laboratories Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Charles River Laboratories Plasmid DNA CDMO Service Product Portfolio
  30. 8.5.5 Charles River Laboratories Recent Developments
  31. 8.6 PackGene
  32. 8.6.1 PackGene Company Information
  33. 8.6.2 PackGene Business Overview
  34. 8.6.3 PackGene Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PackGene Plasmid DNA CDMO Service Product Portfolio
  36. 8.6.5 PackGene Recent Developments
  37. 8.7 Catalent Biologics
  38. 8.7.1 Catalent Biologics Company Information
  39. 8.7.2 Catalent Biologics Business Overview
  40. 8.7.3 Catalent Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Catalent Biologics Plasmid DNA CDMO Service Product Portfolio
  42. 8.7.5 Catalent Biologics Recent Developments
  43. 8.8 Patheon
  44. 8.8.1 Patheon Company Information
  45. 8.8.2 Patheon Business Overview
  46. 8.8.3 Patheon Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Patheon Plasmid DNA CDMO Service Product Portfolio
  48. 8.8.5 Patheon Recent Developments
  49. 8.9 Mycenax Biotech Inc
  50. 8.9.1 Mycenax Biotech Inc Company Information
  51. 8.9.2 Mycenax Biotech Inc Business Overview
  52. 8.9.3 Mycenax Biotech Inc Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mycenax Biotech Inc Plasmid DNA CDMO Service Product Portfolio
  54. 8.9.5 Mycenax Biotech Inc Recent Developments
  55. 8.10 VGXI
  56. 8.10.1 VGXI Company Information
  57. 8.10.2 VGXI Business Overview
  58. 8.10.3 VGXI Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 VGXI Plasmid DNA CDMO Service Product Portfolio
  60. 8.10.5 VGXI Recent Developments
  61. 8.11 Esco Aster
  62. 8.11.1 Esco Aster Company Information
  63. 8.11.2 Esco Aster Business Overview
  64. 8.11.3 Esco Aster Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Esco Aster Plasmid DNA CDMO Service Product Portfolio
  66. 8.11.5 Esco Aster Recent Developments
  67. 8.12 Eurogentec
  68. 8.12.1 Eurogentec Company Information
  69. 8.12.2 Eurogentec Business Overview
  70. 8.12.3 Eurogentec Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eurogentec Plasmid DNA CDMO Service Product Portfolio
  72. 8.12.5 Eurogentec Recent Developments
  73. 8.13 53Biologics
  74. 8.13.1 53Biologics Company Information
  75. 8.13.2 53Biologics Business Overview
  76. 8.13.3 53Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 53Biologics Plasmid DNA CDMO Service Product Portfolio
  78. 8.13.5 53Biologics Recent Developments
  79. 8.14 SK pharmteco
  80. 8.14.1 SK pharmteco Company Information
  81. 8.14.2 SK pharmteco Business Overview
  82. 8.14.3 SK pharmteco Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 SK pharmteco Plasmid DNA CDMO Service Product Portfolio
  84. 8.14.5 SK pharmteco Recent Developments
  85. 8.15 Cytovance Biologics
  86. 8.15.1 Cytovance Biologics Company Information
  87. 8.15.2 Cytovance Biologics Business Overview
  88. 8.15.3 Cytovance Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cytovance Biologics Plasmid DNA CDMO Service Product Portfolio
  90. 8.15.5 Cytovance Biologics Recent Developments
  91. 8.16 Aldevron
  92. 8.16.1 Aldevron Company Information
  93. 8.16.2 Aldevron Business Overview
  94. 8.16.3 Aldevron Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aldevron Plasmid DNA CDMO Service Product Portfolio
  96. 8.16.5 Aldevron Recent Developments
  97. 8.17 Bionova Scientific
  98. 8.17.1 Bionova Scientific Company Information
  99. 8.17.2 Bionova Scientific Business Overview
  100. 8.17.3 Bionova Scientific Plasmid DNA CDMO Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bionova Scientific Plasmid DNA CDMO Service Product Portfolio
  102. 8.17.5 Bionova Scientific Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst